1832 Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.7M | Sell |
56,957
-2,382
| -4% | -$365K | 0.01% | 378 |
|
|
2025
Q4 | $8.18M | Buy |
59,339
+52,139
| +724% | +$6.83M | 0.01% | 383 |
|
|
2025
Q3 | $923K | Buy |
7,200
+698
| +11% | +$85.2K | ﹤0.01% | 580 |
|
|
2025
Q2 | $787K | Buy |
6,502
+160
| +3% | +$18K | ﹤0.01% | 583 |
|
|
2025
Q1 | $707K | Buy |
6,342
+198
| +3% | +$21.1K | ﹤0.01% | 581 |
|
|
2024
Q4 | $598K | Sell |
6,144
-212
| -3% | -$22.6K | ﹤0.01% | 599 |
|
|
2024
Q3 | $731K | Buy |
6,356
+200
| +3% | +$22.7K | ﹤0.01% | 613 |
|
|
2024
Q2 | $655K | Sell |
6,156
-439
| -7% | -$44.1K | ﹤0.01% | 604 |
|
|
2024
Q1 | $638K | Sell |
6,595
-3,004
| -31% | -$308K | ﹤0.01% | 603 |
|
|
2023
Q4 | $969K | Buy |
9,599
+3,081
| +47% | +$297K | ﹤0.01% | 575 |
|
|
2023
Q3 | $629K | Sell |
6,518
-144
| -2% | -$14.6K | ﹤0.01% | 603 |
|
|
2023
Q2 | $672K | Sell |
6,662
-4,500
| -40% | -$450K | ﹤0.01% | 604 |
|
|
2023
Q1 | $1.03M | Buy |
11,162
+427
| +4% | +$37.3K | ﹤0.01% | 590 |
|
|
2022
Q4 | $974K | Sell |
10,735
-1,161
| -10% | -$97.8K | ﹤0.01% | 624 |
|
|
2022
Q3 | $904K | Sell |
11,896
-366
| -3% | -$30.3K | ﹤0.01% | 616 |
|
|
2022
Q2 | $1.04M | Sell |
12,262
-906
| -7% | -$79.5K | ﹤0.01% | 615 |
|
|
2022
Q1 | $1.14M | Buy |
13,168
+189
| +1% | +$16.4K | ﹤0.01% | 624 |
|
|
2021
Q4 | $1.15M | Buy |
12,979
+313
| +2% | +$26K | ﹤0.01% | 436 |
|
|
2021
Q3 | $1.04M | Sell |
12,666
-725
| -5% | -$65.2K | ﹤0.01% | 483 |
|
|
2021
Q2 | $1.22M | Sell |
13,391
-2,702
| -17% | -$241K | ﹤0.01% | 460 |
|
|
2021
Q1 | $1.31M | Sell |
16,093
-724
| -4% | -$65K | ﹤0.01% | 428 |
|
|
2020
Q4 | $1.5M | Buy |
16,817
+1,267
| +8% | +$111K | ﹤0.01% | 474 |
|
|
2020
Q3 | $1.26M | Buy |
15,550
+1,812
| +13% | +$157K | ﹤0.01% | 463 |
|
|
2020
Q2 | $1.1M | Sell |
13,738
-51,368
| -79% | -$4.43M | ﹤0.01% | 444 |
|
|
2020
Q1 | $5.26M | Buy |
65,106
+53,803
| +476% | +$4.8M | 0.02% | 291 |
|
|
2019
Q4 | $973K | Buy |
11,303
+6,465
| +134% | +$580K | ﹤0.01% | 431 |
|
|
2019
Q3 | $422K | Sell |
4,838
-422
| -8% | -$37.9K | ﹤0.01% | 480 |
|
|
2019
Q2 | $480K | Sell |
5,260
-1,148
| -18% | -$97.2K | ﹤0.01% | 502 |
|
|
2019
Q1 | $549K | Buy |
6,408
+295
| +5% | +$23.7K | ﹤0.01% | 414 |
|
|
2018
Q4 | $471K | Sell |
6,113
-234
| -4% | -$18.2K | ﹤0.01% | 430 |
|
|
2018
Q3 | $491K | Buy |
6,347
+872
| +16% | +$64.5K | ﹤0.01% | 476 |
|
|
2018
Q2 | $396K | Buy |
5,475
+345
| +7% | +$23.8K | ﹤0.01% | 455 |
|
|
2018
Q1 | $371K | Sell |
5,130
-1,287
| -20% | -$98K | ﹤0.01% | 463 |
|
|
2017
Q4 | $481K | Sell |
6,417
-27,781
| -81% | -$2.1M | ﹤0.01% | 465 |
|
|
2017
Q3 | $2.63M | Sell |
34,198
-113,464
| -77% | -$8.57M | 0.01% | 338 |
|
|
2017
Q2 | $11M | Sell |
147,662
-66,149
| -31% | -$4.69M | 0.05% | 242 |
|
|
2017
Q1 | $14.2M | Sell |
213,811
-3,588,700
| -94% | -$239M | 0.05% | 225 |
|
|
2016
Q4 | $215M | Buy |
3,802,511
+3,288,029
| +639% | +$213M | 0.36% | 70 |
|
|
2016
Q3 | $36.4M | Buy |
514,482
+15,557
| +3% | +$1.13M | 0.14% | 153 |
|
|
2016
Q2 | $37.1M | Buy |
498,925
+117,765
| +31% | +$8.14M | 0.14% | 143 |
|
|
2016
Q1 | $37.9M | Sell |
381,160
-454,982
| -54% | -$31M | 0.09% | 178 |
|
|
2015
Q4 | $65.8M | Buy |
836,142
+208,636
| +33% | +$16.6M | 0.28% | 91 |
|
|
2015
Q3 | $51.8M | Buy |
627,506
+81,049
| +15% | +$7.21M | 0.22% | 101 |
|
|
2015
Q2 | $48M | Buy |
546,457
+121,373
| +29% | +$11.1M | 0.16% | 136 |
|
|
2015
Q1 | $37.6M | Sell |
425,084
-324
| -0.1% | -$28.7K | 0.14% | 137 |
|
|
2014
Q4 | $35.3M | Buy |
425,408
+7,924
| +2% | +$657K | 0.11% | 160 |
|
|
2014
Q3 | $35.2M | Buy |
417,484
+179,162
| +75% | +$14.5M | 0.12% | 166 |
|
|
2014
Q2 | $19.3M | Buy |
238,322
+238,210
| +212,688% | +$18.7M | 0.06% | 224 |
|
|
2014
Q1 | $9K | Sell |
112
-28,085
| -100% | -$2.05M | ﹤0.01% | 557 |
|
|
2013
Q4 | $2.03M | Buy |
+28,197
| New | +$1.96M | 0.01% | 370 |
|
Other funds holding NVS
1832 Asset Management's NVS Position: Q1 2026 in Review
1832 Asset Management reduced its Novartis (NVS) stake by 4% in Q1 2026, selling an estimated $365K and leaving 56,957 shares worth $8.7M. The position accounts for 0.01% of the portfolio, ranked #378.
1832 Asset Management first reported a position in NVS in Q4 2013 and has held it in 50 quarters since. The position peaked at $215M in Q4 2016. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- 1832 Asset Management held 56,957 shares of Novartis worth $8.7M as of Q1 2026.
- 1832 Asset Management sold 2,382 Novartis shares in Q1 2026, an estimated $365K.
- Novartis made up 0.01% of 1832 Asset Management's portfolio in Q1 2026, its #378 holding.
- 1832 Asset Management first reported a position in Novartis in Q4 2013 and has held it in 50 quarters since.
- 1832 Asset Management's Novartis position peaked at $215M in Q4 2016.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.